Angina pectoris efter sumatriptan (Imigran).

B. Abrahamsen*, B. D. Christiansen

*Corresponding author af dette arbejde

    Publikation: Bidrag til tidsskriftArtikelForskningpeer review

    Abstract

    Developed for the treatment of migraine, sumatriptan is an agonist of 5-hydroxytryptamine-1-receptors. Though a pressure sensation is a common complaint, significant ECG changes have not been reported after subcutaneous administration of sumatriptan. A case history is given where angina pectoris after sumatriptan self-administration was experienced on two occasions by a 61-year old man with a history of minor myocardial infarction--without post-infarction angina--two years previously. The angina after sumatriptan was accompanied on both occasions by significant ST-segment depression on ECG-monitoring. An extracranial vasoconstrictor action of sumatriptan in patients with ischaemic heart disease is suggested.

    Bidragets oversatte titelAngina pectoris after sumatriptan (Imigran)
    OriginalsprogDansk
    Sider (fra-til)3602-3603
    Antal sider2
    TidsskriftUgeskrift for laeger
    Vol/bind154
    Udgave nummer50
    StatusUdgivet - 7 dec. 1992

    Fingeraftryk

    Udforsk hvilke forskningsemner 'Angina pectoris efter sumatriptan (Imigran).' indeholder.

    Citationsformater